COMPARE · Data as of August 21, 2026

AHR vs OHI

Verdict: Side-by-side breakdown using the Bull Rankings model. AHR scored 78.0, OHI scored 72.0 — AHR leads.
Compare another set
AHR
American Healthcare REIT, Inc.
REIT - Healthcare Facilities · Financial strength
43.3Fin
$55.93 · $12.2B
fundamentals as of
Strength gap
31.1
OHI leads
OHI
Omega Healthcare Investors, Inc.
REIT - Healthcare Facilities · Financial strength
74.4Fin
$46.61 · $14.9B
fundamentals as of
  • Fastest growthOHI+13.2%
  • Strongest balance sheetAHR0.42
THE BULL RANKINGS SCORECARD43.3/ 100 · FIN STRENGTHPEER MEDIANREIT43.3
THE BULL RANKINGS SCORECARD74.4/ 100 · FIN STRENGTHPEER MEDIANREIT74.4
YieldAHR1.8%OHI5.8%
RevAHR+9.1%OHI+13.2%
D/EAHR0.42OHI0.71
AHR
OHI
1.8%C+
Yield
5.8%A-
+9.1%B
Rev
+13.2%B+
0.42A
D/E
0.71B+
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
AHRAmerican Healthcare REIT, Inc.
REIT - Healthcare Facilities · $55.93 · beta 0.77
Why now
REIT - Healthcare Facilities · market cap $12.2b. 5% off the 52-week high of $58.70. 15 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $63.67 (implying +14% upside).
Moat
Moat signals from the quantitative card are modest — profitability and capital efficiency are middle-of-pack. The thesis here depends on softer factors (switching costs, brand, distribution, regulatory protection) not captured by the quality-growth screen.
Risk
Net margin 4.8% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first. ROE 4% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
OHIOmega Healthcare Investors, Inc.
REIT - Healthcare Facilities · $46.61 · beta 0.58
Why now
REIT - Healthcare Facilities · market cap $14.9b. 11% off the 52-week high of $52.39. Revenue growing +13%, comfortably above the S&P median. 18 sell-side analysts rate this a Buy with a mean 1-yr target of $51.94 (implying +11% upside).
Moat
Net margin 68% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 17% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
Dividend payout 95% of earnings on a 5.8% yield — distribution coverage is thin; one earnings stumble could force a dividend cut. P/S 11.8x embeds aggressive forward growth — disappointing top-line guidance would compress the multiple hard.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.